Phenotypic Differences of CD103+ Tissue-Resident Memory T Cells Associated with Various Cancers

被引:1
|
作者
Park, Hye Seon [1 ,2 ]
Jeon, Yeonjin [1 ]
Lee, Hyun [1 ]
Lee, Heejae [1 ]
Kim, Young-Ae [2 ]
Park, In Ah [3 ]
Bang, Won Seon [1 ,2 ]
Lee, Miseon [1 ]
Cho, Young Jin [1 ,2 ]
Kim, Jihyeong [1 ,2 ]
Gong, Gyungyub [1 ]
Lee, Hee Jin [1 ,2 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Dept Pathol, Coll Med, Seoul, South Korea
[2] Univ Ulsan, Asan Med Ctr, Asan Med Inst Convergence Sci & Technol AMIST, Biomed Sci,Coll Med, Seoul, South Korea
[3] Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul, South Korea
关键词
Human cancer; Single cell; CD103; Tissue-resident memory T cell; TUMOR-INFILTRATING LYMPHOCYTES; FAVORABLE PROGNOSIS; LUNG-CANCER; EFFECTOR; SPHINGOSINE-1-PHOSPHATE; MATURATION; ENGAGEMENT; SURVIVAL; PROMOTES; PREDICT;
D O I
10.1159/000518972
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background/Aims: The presence and clinical importance of tissue-resident memory T (T-RM) cells have been recently described in association with various cancer types. However, the frequency and the traditional naive-effector-memory phenotypic characteristics of T-RM cells are largely unknown. Methods: We analyzed single-cell populations of colorectal cancer (CC, n = 18), stomach cancer (SC, n = 13), renal cell carcinoma (RCC, n = 19), and breast cancer (BC, n = 16) by dissociation of tumor tissue with collagenase/hyaluronidase. We investigated populations of naive, effector, and memory T and T-RM cells by flow cytometry. Results: Among CD8(-) cells, CC was associated with a significantly higher proportion of CD103(+) T cells than other tumor types (p < 0.001). Among CD8(+) cells, CC and SC were associated with higher CD103(+) T-cell proportions than RCC and BC (p < 0.001). Significantly more CD8(+) than CD8(-) cells expressed CD103 (p < 0.001). In association with SC, RCC, and BC, CD8(+) T cells had a similar T-cell phenotype composition pattern: fewer effector T cells and more memory-type T cells among CD103(+) cells compared with CD103(-) cells (p < 0.05). Tumors with higher proportion of CD103(+) cells had no specific clinicopathologic characteristics than those with lower proportion of CD103(+) cells. Conclusion: T-RM cell abundance and phenotypes varied among CC, SC, RCC, and BC. Further studies regarding the functional differences of T-RM associated with various tumors are warranted. </p>
引用
收藏
页码:116 / 126
页数:11
相关论文
共 50 条
  • [1] Significance of CD103+ tissue-resident memory T cells for predicting the effectiveness of immune checkpoint inhibitors in esophageal cancer
    Natsuki, Seiji
    Tanaka, Hiroaki
    Nishiyama, Masaki
    Deguchi, Sota
    Miki, Yuichiro
    Yoshii, Mami
    Tamura, Tatsuro
    Toyokawa, Takahiro
    Lee, Shigeru
    Maeda, Kiyoshi
    BMC CANCER, 2023, 23 (01)
  • [2] Significance of CD103+ tissue-resident memory T cells for predicting the effectiveness of immune checkpoint inhibitors in esophageal cancer
    Seiji Natsuki
    Hiroaki Tanaka
    Masaki Nishiyama
    Sota Deguchi
    Yuichiro Miki
    Mami Yoshii
    Tatsuro Tamura
    Takahiro Toyokawa
    Shigeru Lee
    Kiyoshi Maeda
    BMC Cancer, 23
  • [3] Tumor-Infiltrating CD103+ Tissue-Resident Memory T Cells and CD103-CD8+ T Cells in HNSCC Are Linked to Outcome in Primary but not Metastatic Disease
    von Witzleben, Adrian
    Ellis, Matthew
    Thomas, Gareth J.
    Hoffmann, Thomas K.
    Jackson, Richard
    Laban, Simon
    Ottensmeier, Christian H.
    CLINICAL CANCER RESEARCH, 2024, 30 (01) : 224 - 234
  • [4] The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin
    Mackay, Laura K.
    Rahimpour, Azad
    Ma, Joel Z.
    Collins, Nicholas
    Stock, Angus T.
    Hafon, Ming-Li
    Vega-Ramos, Javier
    Lauzurica, Pilar
    Mueller, Scott N.
    Stefanovic, Tijana
    Tscharke, David C.
    Heath, William R.
    Inouye, Michael
    Carbone, Francis R.
    Gebhardt, Thomas
    NATURE IMMUNOLOGY, 2013, 14 (12) : 1294 - +
  • [5] ImmunoPET provides a novel way to visualize the CD103+ tissue-resident memory T cell to predict the response of immune checkpoint inhibitors
    Fan, Xiaoyu
    Nijman, Hans W.
    de Bruyn, Marco
    Elsinga, Philip H.
    EJNMMI RESEARCH, 2024, 14 (01)
  • [6] Distribution, phenotype, functional and clinical relevance of CD8+CD103+ tissue-resident memory T cells in human gastric cancer
    Shen, Yang
    Li, Xiao-long
    Li, Yu-xian
    Shan, Zhi-guo
    Zhao, Yong-liang
    Cheng, Ping
    Zhao, Zhuo
    Zhang, Jin-yu
    Chen, Weisan
    Zhuang, Yuan
    Ma, Dai-yuan
    Zou, Quan-ming
    Qiu, Yuan
    Peng, Liu-sheng
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (07) : 1645 - 1654
  • [7] Tissue-resident memory CD8+ T cells in cancer immunology and immunotherapy
    Wang, Ting
    Shen, Yifei
    Luyten, Sophie
    Yang, Yexin
    Jiang, Xiaodong
    PHARMACOLOGICAL RESEARCH, 2020, 159
  • [8] Transcriptional programming of tissue-resident memory CD8+ T cells
    Milner, J. Justin
    Goldrath, Ananda W.
    CURRENT OPINION IN IMMUNOLOGY, 2018, 51 : 162 - 169
  • [9] Tissue-Resident Memory CD8+T Cells: Differentiation, Phenotypic Heterogeneity, Biological Function, Disease, and Therapy
    Xu, Luming
    Ye, Lilin
    Huang, Qizhao
    MEDCOMM, 2025, 6 (03):
  • [10] The Emerging Role of Tissue-Resident Memory CD8+ T Lymphocytes in Human Digestive Tract Cancers
    Mei, Xinyu
    Li, Huan
    Zhou, Xinpeng
    Cheng, Min
    Cui, Kele
    FRONTIERS IN ONCOLOGY, 2022, 11